CONTENTS:
- Promoting addiction science after Brexit - What can Addiction and SSA do and what does UK government need to do? [Editorial]. Hickman M., Cousijn J., Marsden J., Hines L., Day E., p. 2597-2599.
- Heroin use cannot be measured adequately with a general population survey [Addiction Opinion and Debate]. Reuter P., Caulkins J.P., Midgette G., p. 2600-2609.
- Household surveys and the case of the Australian methamphetamine situation. McKetin R., p. 2610-2611.
- Significance of integration and use of multiple data sources for understanding substance use and mental health disorders. Radhakrishnan K., p. 2611-2613.
- Data triangulation for substance abuse research. van Hasselt M., p. 2613-2615.
- Pathways to drug prevalence estimation: synthesizing three comments on triangulation. Midgette G., Caulkins J.P., Reuter P., p. 2615-2616.
- Treatment rates for alcohol use disorders: a systematic review and meta-analysis. Mekonen T., Chan G.C.K., Connor J., Hall W., Hides L., Leung J., p. 2617-2634.
- Concurrent validity of the Alcohol Purchase Task for measuring the reinforcing efficacy of alcohol: an updated systematic review and meta-analysis. Martinez-Loredo V., Gonzalez-Roz A., Secades-Villa R., Fernandez-Hermida J.R., MacKillop J., p. 2635-2650.
- Commentary on Martinez-Loredo et al.: Where do we go from here? Increasing the clinical utility of alcohol purchase tasks by expanding our definition of constraint. Acuff S.F., Murphy J.G., p. 2651-2652.
- Hazardous and harmful alcohol use in the Northern Territory, Australia: the impact of alcohol policy on critical care admissions using an extended sampling period. Secombe P., Campbell L., Brown A., Bailey M., Pilcher D., p. 2653-2662.
- Effects of a multi-component alcohol prevention intervention at sporting events: a quasi-experimental control group study. Elgan T.H., Durbeej N., Holder H.D., Gripenberg J., p. 2663-2672.
- Alcohol control policy measures and all-cause mortality in Lithuania: an interrupted time-series analysis. Stelemekas M., Manthey J., Badaras R., Casswell S., Ferreira-Borges C., Kalediene R., et al., p. 2673-2684.
- Mortality in the Americas from 2013 to 2015 resulting from diseases, conditions and injuries which are 100% alcohol-attributable. Chrystoja B.R., Monteiro M.G., Owe G., Gawryszewski V.P., Rehm J., Shield K., p. 2685-2696.
- Evaluating the impact of minimum unit pricing (MUP) on off-trade alcohol sales in Scotland: an interrupted time-series study. Robinson M., Mackay D., Giles L., Lewsey J., Richardson E., Beeston C., p. 2697-2707.
- Commentary on Robinson et al.: England needs minimum pricing to tackle alcohol's hidden harms-Scotland's experience shows minimum unit pricing (MUP) on off-trade alcohol sales is effective. Finlay I.G., Severi K., p. 2708-2709.
- Commentary on Robinson et al. (2021): Evaluating theories of change for public health policies using computer model discovery methods. Purshouse R.C., Buckley C., Brennan A., Holmes J., p. 2709-2711.
- Evaluating the effects of two alcohol reduction counseling interventions on intimate partner violence perpetration: secondary analysis of a three-arm randomized controlled trial among Vietnamese men with HIV. Hershow R.B., Reyes H., Ha T.V., Chander G., Mai N.V.T., Sripaipan T., et al., p. 2712-2723.
- Impact of cumulative incarceration and the post-release period on syringe-sharing among people who inject drugs in Tijuana, Mexico: a longitudinal analysis. Rivera Saldana C.D., Beletsky L., Borquez A., Kiene S.M., Strathdee S.A., Zuniga M.L., et al., p. 2724-2733.
- Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico. Marquez L.K., Fleiz C., Burgos J.L., Cepeda J.A., McIntosh C., Garfein R.S., et al., p. 2734-2745.
- The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre-menstrual dysphoric disorder. Joyce K.M., Thompson K., Good K.P., Tibbo P.G., O'Leary M.E., Perrot T.S., et al., p. 2746-2758.
- Commentary on Joyce et al.: Studying menstrual cycle effects on behavior requires within-person designs and attention to individual differences in hormone sensitivity. Eisenlohr-Moul T.A., p. 2759-2760.
- Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C). Rance J., Lafferty L., Treloar C., p. 2761-2769.
- Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use. Goodwin R.D., Kim J.H., Cheslack-Postava K., Weinberger A.H., Wu M., Wyka K., et al., p. 2770-2778.
- The intermediary role of adolescent temperamental and behavioral traits on the prospective associations between polygenic risk and cannabis use among young adults of European Ancestry. Brick L.A., Benca-Bachman C.E., Bertin L., Martin K.P., Risner V., Palmer R.H.C., p. 2779-2789.
- Opioid use disorder and overdose among youth following an initial opioid prescription. Hadland S.E., Bagley S.M., Gai M.J., Earlywine J.J., Schoenberger S.F., Morgan J.R., et al., p. 2790-2800.
- Encouraging and evaluating limit-setting among on-line gamblers: a naturalistic randomized controlled trial. Heirene R.M., Gainsbury S.M., p. 2801-2813.
- Commentary on Heirene & Gainsbury: Re-thinking prevention in the gambling field through applying the triad universal, selective and indicated preventions. Luquiens A., p. 2814-2815.
- Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors. Beard E., Jackson S.E., Anthenelli R.M., Benowitz N.L., Aubin L.S., McRae T., et al., p. 2816-2824.
- The effectiveness of using e-cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom. McDermott M.S., East K.A., Brose L.S., McNeill A., Hitchman S.C., Partos T.R., p. 2825-2836.
- Moderators of the association between regular smoking exposure and motivation and attempts to quit: a repeat cross-sectional study. Tattan-Birch H., Brown J., Kock L., Shahab L., p. 2837-2846.
- Cytisine versus varenicline for smoking cessation in New Zealand indigenous M?ori: a randomized controlled trial. Walker N., Smith B., Barnes J., Verbiest M., Parag V., Pokhrel S., et al., p. 2847-2858.
- Differential price-responsiveness of smoking behaviors among non-Hispanic African Americans and non-Hispanic whites in the United States. Wang Y., Max W., Yao T., Keeler C., Sung H.Y., p. 2859-2869.
- Food addiction in a large community sample of Canadian adults: prevalence and relationship with obesity, body composition, quality of life and impulsivity. Minhas M., Murphy C.M., Balodis I.M., Samokhvalov A.V., MacKillop J., p. 2870-2879.
- Commentary on Minhas et al.: Food addiction - the role of substance and environmental factors. Gearhardt A.N., p. 2880-2881.
- Sex-specific risk profiles for suicide among persons with substance use disorders in Denmark. Adams R.S., Jiang T., Rosellini A.J., Horvath-Puho E., Street A.E., Keyes K.M., et al., p. 2882-2892.
- Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data. Palmateer N.E., McAuley A., Dillon J.F., McDonald S., Yeung A., Smith S., et al., p. 2893-2907.
- Drug-related deaths associated with vaping product use in the United Kingdom. Roberts E., Copeland C., Robson D., McNeill A., p. 2908-2911.
- A new generation of transdermal alcohol biosensing technology: practical applications, machine-learning analytics and questions for future research. Fairbairn C.E., Bosch N., p. 2912-2920.
- Stigma-related arguments against gaming disorder: a call for research. Galanis C.R., Delfabbro P.H., King D.L., p. 2921-2922.
- Call to restore funding to monitor youth exposure to alcohol advertising. Ross C.S., Babor T.F., Bartholow B.D., DeJong W., Fitzgerald N., Jackson K.M., et al., p. 2922-2923.
- Reduction in smoking prevalence and e-cigarettes: an English exception? Braillon A., p. 2924.
- Response to Braillon (2021): No, not the exception. Levy D.T., McNeill A., Jarvis M.J., Brown J., Li Y., p. 2924-2926.